Eliminate the stability dip!

Clinical experience shows that most implant failures occur in the critical early treatment period of the first eight weeks after implant placement. This is due to the delayed healing process of the bone and thus limits the application of novel implant treatment techniques, i.e early loading. Looking at the rapid increase in implants placed and the application of aggressive treatment techniques, there is a growing need to reduce the risk during this early treatment phase.

SLActive has been developed to optimize early implant stability, to reduce the risk during the critical early treatment. Animal test results show that SLActive provides 60% more bone* (compared to SLA^®); these tests in conjunction with clinical results also reveal a significantly improved implant stability after two weeks** (compared to SLA). For the challenges in daily practice, SLActive offers higher treatment predictability and security for clinicians and patients.

* D. Buser, N. Broggini, M. Wieland, R. Schenk, A. Denzer, D. Cochran, B. Hoffmann, A. Lussi, S. Steinemann. Enhanced bone apposition to a chemically advanced SLA titanium surface.
Published 07/2004, JDR 83 (7): 529 – 533, 2004.

** Raghavendra S, Wood MC, Taylor TD. Early wound healing around endosseous implants: a review of the literature. Int J Oral Maxillofac Implants. 2005 May-Jun;20(3):425-31.